TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20197322

Group type: EXPERIMENTAL
Intervention: HPV 16/18 VLP vaccine with AS04 adjuvant (n=13,075)
Number of subjects: 26130

Group type: COMPARATOR
Intervention: Hepatitis A vaccine (control) (n=13,055)
Number of subjects: 26130
Study: 19087694

Group type: EXPERIMENTAL
Intervention: Thymopentin 5 (TP5) combined with prednisone + pyridostigmine for 3 months
Number of subjects: 135

Group type: COMPARATOR
Intervention: Prednisone + pyridostigmine for 3 months (non-TP5 group)
Number of subjects: 135
Study: 15956124

Group type: EXPERIMENTAL
Intervention: Tecadenoson 300 microg/600 microg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Tecadenoson (various doses)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 15311665

Group type: EXPERIMENTAL
Intervention: Separation instruction (judging each square solely in relation to its own category)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integration instruction (ignoring category membership)
Number of subjects: 0
Study: 10878628

Group type: EXPERIMENTAL
Intervention: iodixanol (Visipaque) 320 mg I/ml
Number of subjects: 48

Group type: COMPARATOR
Intervention: iohexol (Omnipaque) 350 mg I/ml
Number of subjects: 48
Study: 9426846

Group type: EXPERIMENTAL
Intervention: Calcijex (1,25(OH)2D3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Injectable One‐Alpha (1(OH)D3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin D3 (Calcijex and injectable One‐Alpha)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral One‐Alpha
Number of subjects: 20
Study: 8262827

Group type: EXPERIMENTAL
Intervention: 40 Gy in 20 fractions
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 20 Gy in 10 fractions
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 8 Gy in 1 fraction
Number of subjects: 71
Study: 3886399

Group type: EXPERIMENTAL
Intervention: BAY l 5240 (nifedipine 10 mg + acebutolol 100 mg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nifedipine 20 mg
Number of subjects: 116
Study: 2465650

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy with methotrexate (MTX) and 5-fluorouracil (5FU)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intra-venous CMFV treatment (in cases with objective remission)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Systemic FACV combination
Number of subjects: 16
Study: 31876292

Group type: EXPERIMENTAL
Intervention: Optimization of rate-adaptive pacing parameters using cardiopulmonary exercise testing (CPET) and pacemaker stress echocardiography (PASE)
Number of subjects: 54
Study: 30092206

Group type: EXPERIMENTAL
Intervention: Movement-to-Music (M2M)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Adapted Yoga (AY)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 81
Study: 28056205

Group type: EXPERIMENTAL
Intervention: Web-Based Cognitive Rehabilitation Program (Insight)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 242
Study: 26270586

Group type: EXPERIMENTAL
Intervention: 16 mg IV dexamethasone
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 24086815

Group type: EXPERIMENTAL
Intervention: Alginate silver dressing (AlSD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Silver zinc sulfadiazine cream (AgZnSD)
Number of subjects: 20
Study: 21256654

Group type: EXPERIMENTAL
Intervention: Ultrasonographic imaging (USI)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 91
Study: 19892663

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) at 500 mg/m(2)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) at 750 mg/m(2)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) at 1,000 mg/m(2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Higher baseline stromal VEGF
Number of subjects: 39
Study: 17047645

Group type: EXPERIMENTAL
Intervention: Letter communication of risk information
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Personal interview communication of risk information
Number of subjects: 87
Study: 15538094

Group type: EXPERIMENTAL
Intervention: losartan/hydrochlorothiazide (50 mg/12.5 mg)
Number of subjects: 585

Group type: COMPARATOR
Intervention: losartan
Number of subjects: 585
Study: 10932333

Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted relaxation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 9306091

Group type: EXPERIMENTAL
Intervention: Fat-free milk (4.9% lactose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-fat milk (8% fat, 4.9% lactose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lactose-free and fat-free control milk
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of fat-free milk and high-fat milk
Number of subjects: 30
Study: 8367786

Group type: EXPERIMENTAL
Intervention: Posterolateral fusion using autogenous bone graft (Group I)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Autogenous posterolateral fusions supplemented by a semi-rigid pedicle screw/plate fixation system (Group II)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Posterolateral autogenous fusion with a rigid pedicle screw/rod fixation system (Group III)
Number of subjects: 124
Study: 2430180

Group type: EXPERIMENTAL
Intervention: Oral tetrahydroaminoacridine (THA)
Number of subjects: 17
Study: 31701317

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance of the PVC tip until it penetrates the lumen (group A)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PVC insertion partially controlled by ultrasound (group B)
Number of subjects: 300

Group type: COMPARATOR
Intervention: PVC without any ultrasound guidance (group C)
Number of subjects: 300
Study: 29033271

Group type: EXPERIMENTAL
Intervention: Surgical module
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Surgical module (naïve subjects)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonmodule
Number of subjects: 30
Study: 27168264

Group type: EXPERIMENTAL
Intervention: Dapsone gel, 7.5%
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 2102
Study: 25008127

Group type: EXPERIMENTAL
Intervention: Web-based guided self-help intervention (Happy@Work), consisting of 6 lessons of problem-solving treatment and cognitive therapy, with weekly assignments and feedback from a coach.
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control as usual (CAU)
Number of subjects: 231
Study: 22853852

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 60
Study: 20688462

Group type: EXPERIMENTAL
Intervention: 100 μg of rhTSH IV 24 h before (123)I
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 100 μg of rhTSH IV 48 h before (123)I
Number of subjects: 7

Group type: COMPARATOR
Intervention: Baseline RAIU with (123)I
Number of subjects: 7
Study: 18279973

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) session
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group assessment (no ECT session)
Number of subjects: 24
Study: 16148718

Group type: EXPERIMENTAL
Intervention: Percutaneous dilatational tracheotomy (PDT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Surgical tracheotomy (ST)
Number of subjects: 43
Study: 12598344

Group type: EXPERIMENTAL
Intervention: 5-FU plus leucovorin (arm A)
Number of subjects: 680

Group type: COMPARATOR
Intervention: 5-FU plus levamisole (arm B)
Number of subjects: 680
Study: 10322096

Group type: EXPERIMENTAL
Intervention: Alpha1-proteinase inhibitor therapy (four intravenous doses)
Number of subjects: 0
Study: 7497557

Group type: EXPERIMENTAL
Intervention: Mivacurium 2 x ED95 (0.150 mg.kg‐1) with priming
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Mivacurium 3 x ED95 (0.215 mg.kg‐1) with priming
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Succinylcholine (1 mg.kg‐1)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Mivacurium 1 x ED95 (0.075 mg.kg‐1) with priming
Number of subjects: 5

Group type: COMPARATOR
Intervention: Mivacurium 2 x ED95 (saline prime)
Number of subjects: 5
Study: 1798310

Group type: EXPERIMENTAL
Intervention: Three-second maximum voluntary isometric contraction (MVIC) with SRHR flexibility technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Six-second maximum voluntary isometric contraction (MVIC) with SRHR flexibility technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ten-second maximum voluntary isometric contraction (MVIC) with SRHR flexibility technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Baseline measurements (three passive stretch trials)
Number of subjects: 60
Study: 7208558

Group type: EXPERIMENTAL
Intervention: 5 mg d-amphetamine
Number of subjects: 10
Study: 30379314

Group type: EXPERIMENTAL
Intervention: 30,000 IU cholecalciferol/week for 6 months
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 26924941

Group type: EXPERIMENTAL
Intervention: Day-case stapes surgery
Number of subjects: 112

Group type: COMPARATOR
Intervention: Inpatient stapes surgery
Number of subjects: 112
Study: 24641841

Group type: EXPERIMENTAL
Intervention: Primary hypofractionated irradiation of the prostate with protons and carbon ions
Number of subjects: 92
Study: 23164526

Group type: EXPERIMENTAL
Intervention: Preoperative checklist
Number of subjects: 200

Group type: COMPARATOR
Intervention: No preoperative checklist
Number of subjects: 200
Study: 20215948

Group type: COMPARATOR
Intervention: Immediate pushing
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Delayed pushing
Number of subjects: 44
Study: 17364906

Group type: EXPERIMENTAL
Intervention: Right median nerve stimulation (RMNS) for 30 min a day, 5 days a week, for 6 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham RMNS for 30 min a day, 5 days a week, for 6 weeks
Number of subjects: 17
Study: 15604945

Group type: EXPERIMENTAL
Intervention: Dynamic 18F‐FDG PET with measured arterial input during hyperinsulinaemic euglycaemic clamping (group A)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dynamic 18F‐FDG PET with estimated input from thoracic images and venous activity during late phase (group B)
Number of subjects: 15
Study: 12066946

Group type: EXPERIMENTAL
Intervention: 100 mg mifepristone as a single dose
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Yuzpe regimen (two tablets each with 50 microg ethinyloestradiol and 0.25 mg levonorgestrel, repeated 12 hours later)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: mifepristone
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Yuzpe regimen
Number of subjects: 1000
Study: 9809007

Group type: EXPERIMENTAL
Intervention: Community mental health system in Kawasaki
Number of subjects: 1250
Study: 7649072

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 6 weeks
Number of subjects: 50
Study: 2678424

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranitidine (150 mg three times daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucralfate plus ranitidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sucralfate at lower pH (1 or 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranitidine pretreatment
Number of subjects: 0
Study: 31004139

Group type: EXPERIMENTAL
Intervention: 600 mg/d of DHA
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 26974214

Group type: EXPERIMENTAL
Intervention: Risperidone long-acting injectable 50 mg
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Risperidone long-acting injectable 25 mg
Number of subjects: 323

Group type: COMPARATOR
Intervention: Risperidone long-acting injectable (both dosages)
Number of subjects: 323
Study: 24272788

Group type: EXPERIMENTAL
Intervention: Flexible laryngoscopy performed by otolaryngologists with various degrees of experience
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Flexible laryngoscopy performed by experienced laryngologists
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Lower levels of pain during laryngoscopy
Number of subjects: 532
Study: 23394502

Group type: EXPERIMENTAL
Intervention: Pranlukast dry syrup (PLK DS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20423844

Group type: EXPERIMENTAL
Intervention: Kidney‐Tonifying plus Blood‐Promoting Recipe
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study: 18681749

Group type: EXPERIMENTAL
Intervention: Risperidone (0.25-2 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 15556128

Group type: EXPERIMENTAL
Intervention: Spatiotemporal experience with locations (four sets of nearby locations learned together in time)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New pattern of spatiotemporal experience introduced to adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consistent new pattern of spatiotemporal organization for children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long delay after initial learning
Number of subjects: 0
Study: 12705563

Group type: EXPERIMENTAL
Intervention: Peer retribution scenarios (4 different scenarios)
Number of subjects: 2604
Study: 9043896

Group type: EXPERIMENTAL
Intervention: 150 IU FSH administered to husbands, either i.m. or s.c., three times a week, starting 3 months before IUI cycles and maintained until the fifth IUI cycle
Number of subjects: 148

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: 150 IU FSH administered to husbands
Number of subjects: 148
Study: 1759767

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 6176794

Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg three times daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30628084

Group type: EXPERIMENTAL
Intervention: 3D endoscope
Number of subjects: 92

Group type: COMPARATOR
Intervention: 2D endoscope
Number of subjects: 92
Study: 29088928

Group type: EXPERIMENTAL
Intervention: Lithium (target serum concentration, 0.80-0.99 mEq/L)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Divalproex (target serum valproate concentration, 80-99 μg/mL)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Adjunctive risperidone
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Tremor
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Target concentrations achievement
Number of subjects: 224
Study: 27881256

Group type: EXPERIMENTAL
Intervention: Self-Management Program (SMP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ordinary care (Control)
Number of subjects: 90
Study: 25103148

Group type: COMPARATOR
Intervention: Imiquimod, 5%, cream (44 patients)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Intralesional Mycobacterium w (Mw) vaccine (45 patients)
Number of subjects: 89
Study: 22552800

Group type: EXPERIMENTAL
Intervention: Plasma NMR
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: NMR in plasma and saliva
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Blood NMR
Number of subjects: 43
Study: 19170911

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) after electrical cardioversion (CV)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Signal-averaged electrocardiography (SAECG) after CV
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Echocardiography after CV
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) after 1 month in SR
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (matched subjects without history of AF)
Number of subjects: 26
Study: 17586422

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs) 1.7 g
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control treatment (olive oil)
Number of subjects: 30
Study: 14513268

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (1 microg) plus calcium (500 mg)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Vitamin D (1000 IU) plus calcium (500 mg)
Number of subjects: 204
Study: 11688520

Group type: EXPERIMENTAL
Intervention: Gemcitabine (G) plus Epirubicin (E) plus Taxol (T) (GET)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy (HDCT) after GET
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: GET
Number of subjects: 36
Study: 9679578

Group type: EXPERIMENTAL
Intervention: Hangeshashin-to (TJ-14)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 41
Study: 8851643

Group type: EXPERIMENTAL
Intervention: Midday light therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Morning light therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Evening light therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Light treatment (general)
Number of subjects: 9
Study: 2256863

Group type: EXPERIMENTAL
Intervention: Condom use for 6 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-condom use for 6 months
Number of subjects: 46
Study: 540522

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasone butyrate cream
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0.1% betamethasone valerate
Number of subjects: 48
Study: 31026433

Group type: EXPERIMENTAL
Intervention: Robotic-assisted minimally invasive esophagectomy (RAMIE)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Open esophagectomy
Number of subjects: 170
Study: 29273759

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) condition using a head-mounted display (HMD) and customized manual wheelchair for self-movement.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Real room condition (implied control group).
Number of subjects: 0
Study: 25637340

Group type: EXPERIMENTAL
Intervention: Whole-breast radiotherapy (40-50 Gy in 15-25 fractions)
Number of subjects: 1326

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Whole-breast radiotherapy
Number of subjects: 1326
Study: 24629635

Group type: EXPERIMENTAL
Intervention: Aptamer-based proteomic technology
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: A logistic regression model combining markers associated with 8-week culture status
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Additional markers
Number of subjects: 39
Study: 21926601

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg/day (HC group)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Saline serum (control group)
Number of subjects: 99
Study: 19036894

Group type: EXPERIMENTAL
Intervention: PRO-CHO (1.2 g CHO + 0.4 g protein x kg(‐1) x h(‐1))
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PRO-CHO
Number of subjects: 6

Group type: COMPARATOR
Intervention: L-CHO (1.2 g CHO x kg(‐1) x h(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: H-CHO (1.6 g CHO x kg(‐1) x h(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: 1.2 g CHO x kg(‐1) x h(‐1)
Number of subjects: 6
Study: 17434014

Group type: EXPERIMENTAL
Intervention: Quin-Lng (levonorgestrel 6 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quin-Ng (quinestrol 3 mg and norgestrel 12 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quin-Ng and Quin-Lng
Number of subjects: 0
Study: 15005721

Group type: EXPERIMENTAL
Intervention: RAB3A gene mutation screening
Number of subjects: 47
Study: 11307656

Group type: EXPERIMENTAL
Intervention: Tramadol (1.5 mg.kg‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propacetamol (2 g)
Number of subjects: 80
Study: 9720832

Group type: EXPERIMENTAL
Intervention: Nafarelin (200 microg intranasal, twice a day for 6 months)
Number of subjects: 55
Study: 10476618

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control
Number of subjects: 500
Study: 1974998

Group type: EXPERIMENTAL
Intervention: CAGE questionnaire
Number of subjects: 915

Group type: COMPARATOR
Intervention: Computer-assisted laboratory profiles
Number of subjects: 915
Study: 364370

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31502659

Group type: EXPERIMENTAL
Intervention: Anterior 90° partial fundoplication
Number of subjects: 191

Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 191
Study: 30954360

Group type: EXPERIMENTAL
Intervention: Intravenous phenobarbital (PB) at 10 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (20 ml of normal saline)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous phenobarbital (PB) at 10 mg/kg (after placebo failure)
Number of subjects: 24
Study: 28950681

Group type: EXPERIMENTAL
Intervention: Annual screening at ages 35-39 and biennial from 41-49
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual screening from 38-42 and triennial from 43-58
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biennial screening from 40-60 years of age
Number of subjects: 0
Study: 26180952

Group type: EXPERIMENTAL
Intervention: Automated consent and data collection processes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of participants' own computer equipment and reliance on big data for outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outsourcing of costly tasks
Number of subjects: 0
Study: 23867733

Group type: COMPARATOR
Intervention: Placebo group (positive instructions of pain relief)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nocebo group (negative instructions of pain increase)
Number of subjects: 36
Study: 21576110

Group type: EXPERIMENTAL
Intervention: Focal intraparietal sulcus lesion (Case H.H.)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Focal intraparietal sulcus lesion (Case N.V.)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Inferior parietal lesion group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Event-related functional MRI (Case H.H.)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Resting-state functional MRI (Case H.H.)
Number of subjects: 2